| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 31 | 32.2x | 17.8x | Bottom tier | |
Growth | 42 | 7.3% | 7.1% | Around median | |
Quality | 73 | 9.7% | 4.5% | Top tier | |
Safety | 78 | 1.4x | 2.6x | Top tier | |
Capital Return | 40 | 1.28% | 2.12% | Around median | |
Momentum | 82 | 40.6% | 2.9% | Top tier | |
Sentiment | 82 | 10 | 3 | Top tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
IDEX Corporation operates through three segments: Health & Science Technologies HST, Fluid & Metering Technologies FMT, and Fire & Safety/Diversified Products FSDP. The company generates revenue from the sale of specialized engineered components and solutions, including high-purity filtration, fluid-flow control, pumps and heaters, optical detection and thermal management technologies, as well as sewer inspection equipment and aviation, fire, and safety products. Its markets include data centers, semiconductors, space and defense, municipal water, mining, and commercial aviation, while recurring revenue represents approximately 50% of the semiconductor portfolio within HST.
In Q2 of fiscal year 2026, revenue according to EDGAR filings was approximately $920.6 million, gross profit was $426.8 million, net income was $143.4 million, and earnings per share were $1.93. Adjusted gross margin was 46.4%, and adjusted EBITDA margin increased by 70 basis points to 28.1%, while adjusted earnings per share reached $2.32 and grew 12%. Operationally, organic sales increased 5%; HST grew 12% and FMT grew 1%, while FSDP declined 1%, demonstrating that HST was the primary growth driver during the quarter.
The analyst consensus is Buy, with an average price target of $254.38, compared with a wide target range of $214 to $280. The average target exceeds the top of the 52-week range of $243.80, but the wide gap between the low and high targets reflects significant variation in estimates of the sustainability of HST growth and the recovery of FMT and FSDP. The data do not include a usable price-to-earnings ratio, so the available assessment is based on the targets and the 52-week range rather than a comparison of earnings multiples.
Figures in the text are as of 2026-08-29; the live price is shown at the top of the page.
Organic sales increased 5%, driven primarily by HST growth of 12%, while FMT grew 1% and FSDP declined 1%. Revenue was $920.6 million and net income was $143.4 million according to EDGAR filings, while adjusted earnings per share reached $2.32. Higher sales volumes, productivity, and the HST business mix contributed to the performance, along with a benefit of $0.08 per share from the IEEPA tariff refund.
Performance Pneumatics provides components for primary and backup power-generation applications, while IDEX also offers liquid-cooling flow-control solutions within data-center infrastructure. In semiconductors, its solutions include high-purity filtration, sealing, optical detection, and thermal management used in process, inspection, and metrology equipment. This exposure helped increase HST orders by 47% in Q2 of fiscal year 2026, and the backlog included data-center business directed toward fiscal year 2027.
Management expects annual organic growth between 5% and 6%, after raising the previous range of 3%–4%. It expects an adjusted EBITDA margin between 27% and 27.3% and adjusted earnings per share between $8.70 and $8.85. For Q3 of fiscal year 2026, it expects organic growth between 5% and 7%, a margin between 27% and 27.5%, and adjusted earnings per share between $2.20 and $2.25.
Automated analysis for informational purposes only — not investment advice.
No. HST is clearly leading the improvement, with organic order growth of 47% and organic sales growth of 12% in Q2 of fiscal year 2026. FMT recorded order growth of 11%, supported by water and mining, but its organic sales increased only 1% due to weakness in agriculture, chemicals, and energy. FSDP orders increased 19% due to BAND-IT and fire and safety, while its sales declined 1% because of lower distribution activity and weakness in some European rescue markets.
The company raised its capital expenditure outlook from $90 million to approximately $110 million, with most of the increase focused on HST capacity required for fiscal years 2027 and 2028. In Q2 of fiscal year 2026, it paid $54 million in dividends and repurchased $77 million of shares, with a plan for quarterly repurchases of approximately $75 million during the remainder of the year. Gross leverage also declined to 1.9 times, and liquidity exceeded $1.1 billion, giving it flexibility between share repurchases and additional acquisitions.
The analyst consensus is Buy, with an average price target of $254.38. Targets range from $214 to $280, while the 52-week range was $158.19–$243.80. The average target exceeds the top of that range, but the wide variation among the targets highlights differing expectations regarding continued HST growth and the conversion of improved orders in FMT and FSDP into actual sales growth.
